Primary malignant melanoma

Malignant melanomas (MM) of the oral cavity are extremely rare, accounting for 0.2% to 8.0% of all malignant melanomas. Malignant melanomas is more frequently seen at the level of the hard palate and gingiva. Early diagnosis and treatment are important for reducing morbidity. Malignant melanoma cells stain positively with antibodies to human melanoma black 45, S-100 protein, and vimentin; therefore, immunohistochemistry can play an important role in evaluating the depth of invasion and the location of metastases. A 76-year-old man developed an oral malignant melanoma, which was originally diagnosed as a bluish reactive denture hyperplasia caused by an ill-fitting lower denture. The tumor was removed surgically, and histopathological examination revealed a nodular-type MM. There was no evidence of recurrence over a 4-year follow-up period. © 2016, Saudi Arabian Armed Forces Hospital. All rights reserved.

Yazar Mısır A.F.
Durmuşlar M.C.
Zerener T.
Gün B.D.
Yayın Türü Article
Tek Biçim Adres https://hdl.handle.net/20.500.12628/7177
Tek Biçim Adres 10.15537/smj.2016.4.15017
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu
Dergi Adı Saudi Medical Journal
Dergi Cilt Bilgisi 37
Dergi Sayısı 4
Sayfalar 446 - 449
Yayın Yılı 2016
Eser Adı
[dc.title]
Primary malignant melanoma
Yazar
[dc.contributor.author]
Mısır A.F.
Yazar
[dc.contributor.author]
Durmuşlar M.C.
Yazar
[dc.contributor.author]
Zerener T.
Yazar
[dc.contributor.author]
Gün B.D.
Yayın Yılı
[dc.date.issued]
2016
Yayıncı
[dc.publisher]
Saudi Arabian Armed Forces Hospital
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
Malignant melanomas (MM) of the oral cavity are extremely rare, accounting for 0.2% to 8.0% of all malignant melanomas. Malignant melanomas is more frequently seen at the level of the hard palate and gingiva. Early diagnosis and treatment are important for reducing morbidity. Malignant melanoma cells stain positively with antibodies to human melanoma black 45, S-100 protein, and vimentin; therefore, immunohistochemistry can play an important role in evaluating the depth of invasion and the location of metastases. A 76-year-old man developed an oral malignant melanoma, which was originally diagnosed as a bluish reactive denture hyperplasia caused by an ill-fitting lower denture. The tumor was removed surgically, and histopathological examination revealed a nodular-type MM. There was no evidence of recurrence over a 4-year follow-up period. © 2016, Saudi Arabian Armed Forces Hospital. All rights reserved.
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
eng
Haklar
[dc.rights]
info:eu-repo/semantics/openAccess
ISSN
[dc.identifier.issn]
0379-5284
İlk Sayfa Sayısı
[dc.identifier.startpage]
446
Son Sayfa Sayısı
[dc.identifier.endpage]
449
Dergi Adı
[dc.relation.journal]
Saudi Medical Journal
Dergi Sayısı
[dc.identifier.issue]
4
Dergi Cilt Bilgisi
[dc.identifier.volume]
37
Tek Biçim Adres
[dc.identifier.uri]
https://dx.doi.org/10.15537/smj.2016.4.15017
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/7177
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
166
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
07 Eylül 2024 06:51
Google Kontrol
Tıklayınız
Malignant melanoma melanomas denture malignant important originally removed ill-fitting caused hyperplasia developed reactive bluish surgically diagnosed histopathological reserved rights Hospital Forces Arabian period examination follow-up 4-year recurrence evidence nodular-type revealed 76-year-old metastases gingiva palate frequently
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms